Evidence map›Paper›PMID 33439527›Full record

ArticleThe Journal of dermatology2021

Development of toxic epidermal necrolysis in a coronavirus disease 2019 patient with recurrence of positive SARS-CoV-2 viral RNA.

Aya Tanaka, Moeko Isei, Chiaki Kikuzawa, Haruna Hinogami, Koji Nishida, Iwao Gohma, Yoshihiko Ogawa

Abstract readCase ReportsLetter
In one paragraph

Article in The Journal of dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aya TanakaDepartment of Dermatology, Sakai City Medical Center, Sakai, Japan.ORCID https://orcid.org/0000-0003-0737-3363
Moeko IseiDepartment of Dermatology, Sakai City Medical Center, Sakai, Japan.
Chiaki KikuzawaDepartment of Dermatology, Sakai City Medical Center, Sakai, Japan.
Haruna HinogamiDepartment of Dermatology, Sakai City Medical Center, Sakai, Japan.ORCID https://orcid.org/0000-0003-1277-8736
Koji NishidaDepartment of Respiratory Medicine, Sakai City Medical Center, Sakai, Japan.
Iwao GohmaDepartment of Respiratory Medicine, Sakai City Medical Center, Sakai, Japan.
Yoshihiko OgawaDepartment of Infectious Diseases, Sakai City Medical Center, Sakai, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aged, 80 and overAntiviral AgentsCOVID-19COVID-19 Drug TreatmentCOVID-19 Nucleic Acid TestingFemaleGlucocorticoidsHumansPulse Therapy, DrugRecurrenceRNA, ViralSARS-CoV-2SkinStevens-Johnson SyndromeSymptom Flare UpTreatment OutcomeAntiviral AgentsGlucocorticoidsRNA, Viral

Identifiers

PMID33439527
PMCPMC8014636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.